RxDoctor Payments DataLook up a doctor →

Daniela Allende, MD

Anatomic Pathology · Cleveland, OHNPI 1942467774

Payments from drug & device makers

$1,616,642in general payments, 2019–2025

Across 105 payments — averaging $15,397 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ventana Medical Systems, Inc.$1.6M
  • Incyte Corporation$2K
  • Novo Nordisk$47
  • Siemens Medical Solutions USA, Inc.$23
$732,966in research payments, 2019–2025

Across 7 payments — averaging $104,709 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novo Nordisk AS$697K
  • Boehringer Ingelheim International GmbH$32K
  • Regeneron$5K

General payments by program year

20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,616,642 in reported general payments places this provider in the 95th percentile of 36 anatomic pathology providers in Ohio.

See all anatomic pathology providers in Ohio

Medicare billing

Part B allowed, 2024
$33,491
Medicare patients
349
Services billed
848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →